1.025

0.49% -0.005

After Hours: 1.03 0.005 +0.49%

180 Life Sciences Corp (ATNF)

Overview News Price History Financials Discussions Forecast Stock Split

180 Life Sciences Corp stock is traded at $1.025, with a volume of 17,911. It is down -0.49% in the last 24 hours and up +15.17% over the past month. 180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.

Previous Close:

$1.03

Open:

$1.03

24h Volume:

17,911

Relative Volume:

0.13

Market Cap:

$5.84M

Revenue:

Net Income/Loss:

$-3.12M

P/E Ratio:

-0.2129

EPS:

-4.8149

Net Cash Flow:

$-2.69M

1W Performance:

+8.80%

1M Performance:

+15.17%

6M Performance:

-54.04%

1Y Performance:

-36.34%

1-Day Range:

$1.00

$1.0484

1-Week Range:

$0.98

$1.14

52-Week Range:

$0.6578

$17.75

180 Life Sciences Corp Stock (ATNF) Company Profile

Name

180 Life Sciences Corp

Sector

Healthcare (1170)

Industry

Biotechnology (667)

Phone

650-507-0669

Address

3000 EL CAMINO REAL, PALO ALTO

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ATNF's Discussions on Twitter

Compare ATNF with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATNF 180 Life Sciences Corp	1.025	5.37M	0	-3.12M	-2.69M	-4.8149
ONC Beone Medicines Ltd Adr	245.58	26.10B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	442.05	111.96B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	42.96M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.20	6.39B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	490.28	63.52B	14.09B	4.50B	2.96B	39.28

180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-15-21	Initiated	Maxim Group	Buy

180 Life Sciences Corp Stock (ATNF) Latest News

May 27, 2025

4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World

May 27, 2025

Best Toy Stocks To Watch Now – May 25th - Defense World

May 27, 2025

May 23, 2025

Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga

May 23, 2025

May 22, 2025

Layoff Tracker: Eikon Cuts Workforce by 15%, Citing ‘External Forces’ - BioSpace

May 22, 2025

May 11, 2025

180 Life Sciences’ (ATNF) Sell (E+) Rating Reiterated at Weiss Ratings - Defense World

May 11, 2025

May 02, 2025

180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program - Barchart.com

May 02, 2025

ATNF’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

May 02, 2025

May 01, 2025

180 Life Sciences Gets Notice of Allowance for Method to Prevent POCD - marketscreener.com

May 01, 2025

MAGIC Nashville Showcases Premier Southeastern Women's Fashion Trends and Innovations - Digital Journal

May 01, 2025

180 Life Sciences (ATNF) Secures Patent Approval for POCD Treatm - GuruFocus

May 01, 2025

180 Life Sciences nears patent for post-surgery cognitive aid By Investing.com - Investing.com India

May 01, 2025

180 Life Sciences nears patent for post-surgery cognitive aid - Investing.com

May 01, 2025

180 Life Sciences Corp. Announces Notice of Allowance for U.S. P - GuruFocus

May 01, 2025

180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction | ATNF Stock News - GuruFocus

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

Patent Breakthrough: 180 Life Sciences Develops First Treatment to Prevent Post-Surgery Cognitive Decline in Elderly - Stock Titan

May 01, 2025

Apr 30, 2025

Budapest Draws in Summer Visitors for an Adventure Along the Danube - Digital Journal

Apr 30, 2025

180 Life Sciences (ATNF) Restructures Capital with Share Repurch - GuruFocus

Apr 30, 2025

180 Life Sciences to buy back shares, simplifies capital structure By Investing.com - Investing.com India

Apr 30, 2025

180 Life Sciences Settles Disputes with Elray Resources - TipRanks

Apr 30, 2025

180 Life Sciences Corp. Announces Share Repurchase | ATNF Stock News - GuruFocus

Apr 30, 2025

180 Life Sciences to buy back shares, simplifies capital structure - Investing.com Australia

Apr 30, 2025

180 Life Sciences Launches Massive 23% Share Reduction Plan: Key Details of $1M Strategic Buyback - Stock Titan

Apr 30, 2025

180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Increase in Short Interest - Defense World

Apr 30, 2025

Short Interest in Adlai Nortye Ltd. (NASDAQ:ANL) Decreases By 51.6% - Defense World

Apr 30, 2025

Apr 29, 2025

Q4 Results This Week: BPCL, Varun Beverages, Vedanta, SBI, Trent Among 180+ Companies To Declare Earnings - NDTV Profit

Apr 29, 2025

Apr 27, 2025

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire

Apr 27, 2025

Apr 26, 2025

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire

Apr 26, 2025

Apr 25, 2025

180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World

Apr 25, 2025

Dupuytren's Disease Market Valuation Expected To Reach $8.54 Billion By 2029 Growing At A Rate Of 9% As Rev... - WhaTech

Apr 25, 2025

Apr 19, 2025

Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 19, 2025

Apr 17, 2025

Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Apr 17, 2025

Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings - Yahoo Finance

Apr 17, 2025

Apr 14, 2025

Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Apr 14, 2025

Apr 11, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World

Apr 09, 2025

180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter

Apr 09, 2025

Apr 08, 2025

ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India

Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 08, 2025

Apr 05, 2025

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire

Apr 05, 2025

Apr 02, 2025

Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences - Siemens press

Apr 02, 2025

Mar 31, 2025

180 Life Sciences Corp. SEC 10-K Report - TradingView

Mar 31, 2025

ATNF stock touches 52-week low at $0.98 amid market shifts - Investing.com

Mar 31, 2025